Curi Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Curi Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $285,630 - $338,226	4,171 New	4,171 $300,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $2,469 - $2,719	34 Added 2.57%	1,357 $104,000
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $41,007 - $49,171	667 Added 101.68%	1,323 $96,000
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $35,181 - $41,013	656 New	656 $40,000
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $139,627 - $157,039	-2,353 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$57.74 - $65.43 $135,862 - $153,956	2,353 New	2,353 $146,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.